Novosanis

game-changing medical devices #collipee #medtech #ivd #meddev #healthcare #HPV #cervicalcancer #urooncology

[Novosanis @Novosanis]

https://t.co/RkOgPvc4Jl

[OraSure Technologies @orasure]

🎄✨ Season's Greetings from OraSure Technologies, Inc.! ✨🎄

As the year comes to a close, we want to take a moment to express our heartfelt gratitude to each and every member of our incredible community.

#HappyHolidays #OraSureTechnologies

[Novosanis @Novosanis]

https://t.co/EQDRv5Ny1r! @AquariusPH and the @OfficialUoM conducted a major health economics study, featuring the Colli-Pee™ #urine collection device, comparing the theoretical costs of sampling strategies for #HPV screening.

Here’s a brief summary of their study:

[The Guinn lab @GuinnLab]

@fraoch0791 and @BarbaraGuinn1 at #EACR2023 enjoying the poster session. It’s a great conference and lots of interest in urine biomarkers for early diagnosis of #endometriosis. And always lovely to spend time with my friends from ⁦@Novosanis⁩ #colli-pee #biomarkers #Turin

[Novosanis @Novosanis]

We are excited to share with you the latest addition to Novosanis' first-void urine collection devices - the Colli-Pee™ UAS™ 10mL device (FV-5010-RUO) for research use only.
Learn more here.
https://t.co/PvtGEf1PcE

[Novosanis @Novosanis]

Are you attending #IPVC in Washington, DC? Don't miss the chance to visit us at booth 11 to discuss how to leverage the at-home, self-sampling screening methods of first-void urine with the Colli-Pee™ device.

[Novosanis @Novosanis]

We're at #IPVC and Koen Beyers will be presenting on the exciting opportunities created by the Colli-Pee™ device, how it can be used with validated assays to detect HPV in first-void urine, and how that could expand cervical cancer screening and diagnosis programs.

[Novosanis @Novosanis]

We'll be exhibiting at the International Papillomavirus Conference (IPVC) meeting in Washington DC, Monday the 17th through the 21st. Schedule time to discuss how to leverage the at-home, self-sampling with the Colli-Pee™ device. #IPVC2023 #HPVprevention
https://t.co/tEZ36QvLl8

[Novosanis @Novosanis]

Today marks our 10th year as Novosanis! 💚

We would not have been able to reach this milestone without our people. Thank you for the time and commitment you have shown the company. We are so grateful for you.

[Novosanis @Novosanis]

#DYK that HPV is linked to cervical cancer?

That's why regular screening, & access to screening is so important. Learn how first-void urine can be used for HPV detection here: https://t.co/OUN9YS4cOB #onelessworry #hpvawarenessday

[Novosanis @Novosanis]

Early detection can signficantly increase chances of survival of #prostatecancer. Did you know urine contains several biomarkers for this cancer type.

Learn more in our white paper - https://t.co/ZgqcJhaIv7

#NationalCancerPreventionMonth

[Novosanis @Novosanis]

During #NationalCancerPreventionMonth, we focus on how self-sampling collection techniques can improve #cancer screening.

For #cervicalcancer screening, women have shown a higher preference to using #urine. Tune in our podcast to learn more - https://t.co/i9GXkEEk4c

[Novosanis @Novosanis]

While #condoms are the first line of defense for STI prevention, routine #screening is also critical.
Read more about #urine in expanding STI screening - https://t.co/Oj8YhWxlID

#WorldCondomDay

[Novosanis @Novosanis]

Today is our last day at the #EUROGIN, so visit us if you haven't yet at booth B07. Our team will be happy to share with you our latest work in urine sampling with our Colli-Pee® device, and its applications for #HPV and #cervicalcancer screening.

[Novosanis @Novosanis]

Don't miss our Scientific Session at #EUROGIN today from 16:30-18:00 CET, which will highlight urine as a sample type for cancer detection. Our colleague, Stephanie Jordaens, will be sharing her insights in the field.

[Novosanis @Novosanis]

Hello from Spain! #EUROGIN

Find us on the exhibition floor (booth B07) to learn more about our urine sampling device, Colli-Pee®, and its applications for HPV and cervical cancer screening. #cancerscreening #HPV #cervicalcancer

[Novosanis @Novosanis]

We invite you to review our scientific poster at #EUROGIN:

Nette Meers - 'Validation of Colli-Pee™ UCM™ FV-5004: A user-friendly device for volumetric first-void urine collection and HPV DNA preservation compatible with high-throughput instruments'. (P 13-5)

#HPVConference

[Novosanis @Novosanis]

We're at #EUROGIN. Stop by to review our scientific poster:

Jhana Hendrickx - 'Home-based self-sampling of first void urine for hrHPV testing in the CASUS study: Attitudes and preferences from a Belgian colposcopy referral population'.
(P 37-1)

#HPVConference

[Novosanis @Novosanis]

Hello from Spain! See you tomorrow at #EUROGIN

Find us on the exhibition floor (booth B07) if you're interested in learning more about our urine sampling device, Colli-Pee®, and its applications for #HPV and #cervicalcancer screening.​

#HPVCongress #HPVvirus

[Novosanis @Novosanis]

There's no better time to discuss the correlation between early cancer detection & survival rates than #WorldCancerDay.

Learn about the advantages of #urine as a sample type for the detection of prostate, cervical & bladder cancers: https://t.co/7UItlz9M96

[Novosanis @Novosanis]

The discussions we had at #PMWC23 further emphasized the value of non-invasive sample types, like first-void urine, for #cancerresearch and screening to improve patient care.

Read our key takeaways from @PMWCintl in our latest blog: https://t.co/0Kp9FI0OST